We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Long term immunological perturbations post DAA therapy in chronic HCV/HIV co-infected patients.
- Authors
MORETTI, SONIA; MANCINI, FLAVIA; BORSETTI, ALESSANDRA
- Abstract
Direct-acting antiviral (DAA) therapies are efficacious for the achievement of sustained virologic response (SVR) in almost all treated hepatitis C virus (HCV)-infected patients. However, the impacts of HCV eradication on immune function and chronic immune activation in the long-term remain controversial and limited, especially in patients co-infected with human immunodeficiency virus (HIV). Indeed, although restoration of many immune responses clearly can be observed, several features of immune perturbations persist over time after HCV clearance. Understanding the degree and reasons of the partial recovery of the immune system in chronic HCV/HIV co-infection after HCV elimination is pivotal to avoid disease progression and possible long-term clinical outcomes in cured patients, as well as contributing to the development of immunotherapy drug design.
- Subjects
HEPATITIS C treatment; ANTIVIRAL agents; IMMUNOTHERAPY; DRUG design; IMMUNE system
- Publication
Biocell, 2022, Vol 46, Issue 12, p2695
- ISSN
0327-9545
- Publication type
Article
- DOI
10.32604/biocell.2022.022257